Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating expenses:
Research and development	$ 61,464	$ 42,794
General and administrative	32,552	21,228
Legal settlement	10,000
Total operating expenses	104,016	64,022
Loss from operations	(104,016)	(64,022)
Grant income	5,161	8,835
Other income, net	3,216	334
Net loss	(95,639)	(54,853)
Unrealized loss on available-for-sale securities	(1,568)	(421)
Comprehensive loss attributable to common stockholders	$ (97,207)	$ (55,274)
Net loss per share attributable to common stockholders, basic	$ (2.53)	$ (1.49)
Net loss per share attributable to common stockholders, diluted	$ (2.53)	$ (1.49)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic	37,733,240	36,921,172
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted	37,733,240	36,921,172